🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What’s better than meeting one of your mentors? Meeting two! #mmsm

There are still 2 weeks left to apply for this position in my lab. If you are keen to study AML biology, like metabolism and want to lead a project with huge translational potential then look no further! Always happy to chat informally as well. DM me.

Thanks a lot Hematopoiesis News ! Did not expect that!!! As always, kudos to Maria Moscvin for leading the study and all our collaborators, especially Niccolo Bolli. Happy new year to all and to many more exciting papers to come in 2024. 🍾

Il 27.01 Fondazione AIRC per la ricerca sul cancro rinnova l’iniziativa “Le Arance della Salute” per ricordare come la #prevenzione inizi dalle sane abitudini e per sostenere la #Ricerca sul cancro In #PoliclinicoMi i progetti finanziati da #AIRC sono ben 3 tutti con obiettivi ambiziosi 👉bit.ly/47TL9wW

In my little home #astronomy library, the 3 volumes of Burnham’s Celestial Handbook will always have a special place.🔭 I have the 1976 edition, which I bought in the mid 1990s from a then-new online bookseller called “Amazon” run by some guy in Washington out of his garage./1

Wonder why mutations in TENT5C/FAM46C are so frequent in MM? Our paper just out as early view in Haematologica helps solving the puzzle! doi.org/10.3324/haemat… Let me tell you how we unveil in vivo the benefits of these mutations for MM cells proliferation, and more

Impact of #CHIP on #HCC in individuals with #MASLD #MAFLD #NAFLD - a new pathway to #liver cancer? Niccolo Bolli massimo iavarone Stefano Romeo Jean-Charles Nault Eric Trépo Helen Reeves Alejandro Forner pubmed.ncbi.nlm.nih.gov/38470216/

Thanks for retweeting our paper Robert Z. Orlowski ! Excited to present the strong work of my trainee Paolo Lopedote, soon to be City of Hope Marcel van den Brink Heme-Onc fellow, on CHIP in AL amyloidosis! Another fun collaboration with Niccolo Bolli .

New preprint! We are happy to share the first preprint from Niccolo Bolli Lab! Here we depict for the first time the transcriptional landscape of genotypically-identified polyclonal plasma cells (PCs) in patients affected by PCs dyscrasias. #mmsm Here the link to the biorxiv:

Very happy and excited to be in Milan to visit Niccolo Bolli matteo da vià Antonio Matera Tuong Lab

Happy to see our new story today on Blood Cancer Journal! We integrated #wgs and immune profiling to explore why myeloma relapses after anti-CD38 antibodies. Great collaboration with Università di Torino Università degli Studi di Milano Sylvester Comprehensive Cancer Center University of Miami Istituto Tumori and funded by Fondazione AIRC per la ricerca sul cancro #mmsm (1/3)

ESH (Haematology) Suzanne Lentzsch, MD, PhD a great presentation from Niccolo Bolli lab at #ESHMM2024 how to recognize pPC from cPC based on genetic profiles

#RICERCA #MielomaMultiplo: #MyFirstAIRCGrant per studiare le cellule più resistenti alle terapie. Un progetto disegnato da Matteo Claudio Da Vià, specialista dell’#Ematologia di #PoliclinicoMi, e sostenuto da Fondazione AIRC per la ricerca sul cancro ➡️bit.ly/4kRfTWj

Happy to share our new work out today on Blood Journals Portfolio #Blood where we report CD38 loss as recurrent mechanisms of resistance to anti-CD38 antibody in multiple myeloma. Great collaboration between Memorial Sloan Kettering Cancer Center MSK Department of Medicine U Calgary Heidelberg Myeloma Mayo Clinic #mmsm #wgs

A labor of love! Excited to see this online first. #amyloidosis. It was a treat to collaborate with many friends: Allon Klein Lab, Ray Comenzo, Mario Nuvolone, Niccolo Bolli, Joao Paulo Gygi Lab. Thanks Blood Journals Portfolio! ashpublications.org/blood/article-…

Major Regulatory Milestone in MM: In response to an application by I2TEAMM and International Myeloma Foundation, the European Medicines Agency has officially endorsed MRD as an early endpoint in clinical trials for Myeloma. This marks a transformative step forward in drug development !! Vincent Rajkumar

📣 Cell developmental state matters in B-ALL. Our study out today in ⁦Nature Cancer⁩: Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features | Nature Cancer nature.com/articles/s4301…

Inflamed pPCs have perturbed interactions with the TME leading to immunoparesis and correlate with decreased survival in MM. ow.ly/KN7g50WhBW4 #lymphoidneoplasia #multiplemyeloma